Entries still open for US Clinical Researcher of the Year 2012

by | 2nd Aug 2012 | News

There is still time to enter PharmaTimes’s US Clinical Researcher of the Year competition, which this year focuses on using resources more effectively without compromising patient safety or data quality.

There is still time to enter PharmaTimes’s US Clinical Researcher of the Year competition, which this year focuses on using resources more effectively without compromising patient safety or data quality.

The competition welcomes participants from the following areas of research:

– Study Nurse/Clinical Research Coordinator
– Clinical Research Associates (with varying levels of experience)
– Project Manager working within a contract research organisation (CRO) environment
– Study Leader working within a pharma/sponsor environment
– Clinical Trial Teams

Entries are building fast, with engagement from a broad cross-section of CRO and pharma competitors including: PRA, PPD, Parexel, Chiltern, INC Research, Shire Pharmaceuticals, GSK, Sanofi, Benchmark Research, Endo Pharmaceuticals, MSD, Abbott and Allergan.

Level playing field

Professionals within the clinical research fraternity can compete on a level playing field in this competition, working through a series of competency-based exercises that start with a multiple-choice questionnaire based on ICH/GCP standards and end with a case-study devised to explore different approaches to risk-based or targeted monitoring.

Organised by media company PharmaTimes, the competition is independently judged by a high level Executive Steering Committee drawn from senior pharma clinical leaders within AZ, GSK, MSD, Sanofi, Shire, Endo Pharma, Allergan, Alcon and Stiefel.

The finals day and presentation of the US Clinical Researcher of the Year awards will take place on 8 November and will be hosted by competition sponsors SAS at their Executive Briefing Centre in Cary, North Carolina.

Tags


Related posts